Immunotherapy for Breast Cancer: Current and Future Strategies.

about

Immunotherapy for Breast Cancer: Current and Future Strategies.

Item

http://www.wikidata.org/entity/Q52587066

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Immunotherapy for Breast Cancer: Current and Future Strategies.

@en

Immunotherapy for Breast Cancer: Current and Future Strategies.

@nl

type

Item

label

Immunotherapy for Breast Cancer: Current and Future Strategies.

@en

Immunotherapy for Breast Cancer: Current and Future Strategies.

@nl

prefLabel

Immunotherapy for Breast Cancer: Current and Future Strategies.

@en

Immunotherapy for Breast Cancer: Current and Future Strategies.

@nl

P1476

Immunotherapy for Breast Cancer: Current and Future Strategies

@en

P2093

Austin D Williams

http://www.w3.org/2001/XMLSchema#string

Avery D Posey

http://www.w3.org/2001/XMLSchema#string

Carl H June

http://www.w3.org/2001/XMLSchema#string

Christine Hill

http://www.w3.org/2001/XMLSchema#string

Jose Conejo-Garcia

http://www.w3.org/2001/XMLSchema#string

Julia Tchou

http://www.w3.org/2001/XMLSchema#string

Kyle K Payne

http://www.w3.org/2001/XMLSchema#string

P2860

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Hallmarks of Cancer: The Next Generation

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas

Oncolytic virus therapy: A new era of cancer treatment at dawn

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

DNA vaccine for cancer immunotherapy

P31

scholarly article

P356

10.1007/S40137-017-0194-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29657904

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5894864

http://www.w3.org/2001/XMLSchema#string